Hepatitis C among drug users in Europe is high but there is cause for optimism...

AVERT | 2017-06-27 15:59 UTC

Prevalence of hepatitis C (HCV) among people who inject drugs in Europe is very high – in excess of 50% across six countries in the region and an estimated 84% in Portugal. But a new report released by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) for World Hepatitis Day (July 28), shows that a combination of new treatments and prevention interventions gives significant reason for optimism in curbing the HCV epidemic among drug users in the region.

By AVERT on 2017-06-27 15:59 UTC
  • Need an account?